These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 25965391)
1. Pharmacological characterization of an antisense knockdown zebrafish model of Dravet syndrome: inhibition of epileptic seizures by the serotonin agonist fenfluramine. Zhang Y; Kecskés A; Copmans D; Langlois M; Crawford AD; Ceulemans B; Lagae L; de Witte PA; Esguerra CV PLoS One; 2015; 10(5):e0125898. PubMed ID: 25965391 [TBL] [Abstract][Full Text] [Related]
2. New insights into the early mechanisms of epileptogenesis in a zebrafish model of Dravet syndrome. Tiraboschi E; Martina S; van der Ent W; Grzyb K; Gawel K; Cordero-Maldonado ML; Poovathingal SK; Heintz S; Satheesh SV; Brattespe J; Xu J; Suster M; Skupin A; Esguerra CV Epilepsia; 2020 Mar; 61(3):549-560. PubMed ID: 32096222 [TBL] [Abstract][Full Text] [Related]
3. NaV1.1 and NaV1.6 selective compounds reduce the behavior phenotype and epileptiform activity in a novel zebrafish model for Dravet Syndrome. Weuring WJ; Singh S; Volkers L; Rook MB; van 't Slot RH; Bosma M; Inserra M; Vetter I; Verhoeven-Duif NM; Braun KPJ; Rivara M; Koeleman BPC PLoS One; 2020; 15(3):e0219106. PubMed ID: 32134913 [TBL] [Abstract][Full Text] [Related]
4. Behavioral Comorbidities and Drug Treatments in a Zebrafish Grone BP; Qu T; Baraban SC eNeuro; 2017; 4(4):. PubMed ID: 28812061 [TBL] [Abstract][Full Text] [Related]
5. Fenfluramine increases survival and reduces markers of neurodegeneration in a mouse model of Dravet syndrome. Cha J; Filatov G; Smith SJ; Gammaitoni AR; Lothe A; Reeder T Epilepsia Open; 2024 Feb; 9(1):300-313. PubMed ID: 38018342 [TBL] [Abstract][Full Text] [Related]
6. Successful use of fenfluramine in nonconvulsive status epilepticus of Dravet syndrome. Specchio N; Pietrafusa N; Ferretti A; Trivisano M; Vigevano F Epilepsia; 2020 Apr; 61(4):831-833. PubMed ID: 32167579 [No Abstract] [Full Text] [Related]
7. Drug repurposing for Dravet syndrome in scn1Lab Sourbron J; Partoens M; Scheldeman C; Zhang Y; Lagae L; de Witte P Epilepsia; 2019 Feb; 60(2):e8-e13. PubMed ID: 30663052 [TBL] [Abstract][Full Text] [Related]
9. Serotonergic Modulation as Effective Treatment for Dravet Syndrome in a Zebrafish Mutant Model. Sourbron J; Schneider H; Kecskés A; Liu Y; Buening EM; Lagae L; Smolders I; de Witte P ACS Chem Neurosci; 2016 May; 7(5):588-98. PubMed ID: 26822114 [TBL] [Abstract][Full Text] [Related]
10. Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment. Baraban SC; Dinday MT; Hortopan GA Nat Commun; 2013; 4():2410. PubMed ID: 24002024 [TBL] [Abstract][Full Text] [Related]
11. Microglia Mitigate Neuronal Activation in a Zebrafish Model of Dravet Syndrome. Brenet A; Somkhit J; Csaba Z; Ciura S; Kabashi E; Yanicostas C; Soussi-Yanicostas N Cells; 2024 Apr; 13(8):. PubMed ID: 38667299 [TBL] [Abstract][Full Text] [Related]
12. Activity of drugs and components of natural origin in the severe myoclonic epilepsy of infancy (Dravet syndrome). Berio A; Piazzi A Cent Nerv Syst Agents Med Chem; 2015; 15(2):95-8. PubMed ID: 25924876 [TBL] [Abstract][Full Text] [Related]
13. Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial. Lagae L; Sullivan J; Knupp K; Laux L; Polster T; Nikanorova M; Devinsky O; Cross JH; Guerrini R; Talwar D; Miller I; Farfel G; Galer BS; Gammaitoni A; Mistry A; Morrison G; Lock M; Agarwal A; Lai WW; Ceulemans B; Lancet; 2019 Dec; 394(10216):2243-2254. PubMed ID: 31862249 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: A real-world study. Specchio N; Pietrafusa N; Doccini V; Trivisano M; Darra F; Ragona F; Cossu A; Spolverato S; Battaglia D; Quintiliani M; Luigia Gambardella M; Rosati A; Mei D; Granata T; Dalla Bernardina B; Vigevano F; Guerrini R Epilepsia; 2020 Nov; 61(11):2405-2414. PubMed ID: 32945537 [TBL] [Abstract][Full Text] [Related]
15. Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome. Griffin A; Hamling KR; Knupp K; Hong S; Lee LP; Baraban SC Brain; 2017 Mar; 140(3):669-683. PubMed ID: 28073790 [TBL] [Abstract][Full Text] [Related]
16. Fenfluramine treatment in pediatric patients with Dravet syndrome reduces seizure burden and overall healthcare costs: A retrospective and observational real-world study. Gjerulfsen CE; Nikanorova M; Olofsson K; Johannessen Landmark C; Rubboli G; Møller RS Epilepsia Open; 2024 Oct; 9(5):1891-1900. PubMed ID: 39140199 [TBL] [Abstract][Full Text] [Related]
17. Genetic and Functional Differences between Duplicated Zebrafish Genes for Human Weuring WJ; Hoekman JW; Braun KPJ; Koeleman BPC Cells; 2022 Jan; 11(3):. PubMed ID: 35159264 [TBL] [Abstract][Full Text] [Related]
18. Enhancing the action of serotonin by three different mechanisms prevents spontaneous seizure-induced mortality in Dravet mice. Guo J; Min D; Farrell EK; Zhou Y; Faingold CL; Cotten JF; Feng HJ Epilepsia; 2024 Jun; 65(6):1791-1800. PubMed ID: 38593237 [TBL] [Abstract][Full Text] [Related]